Next, we compared the degree of activation of tumor-infiltrating PD-1+ CD3+ CD+ T cells with tumor-infiltrating PD-1+ CD38− CD+ T cells using CD69 and HLA-DR (Fig. 4g, i), which are the markers of T cell activation. This evidence concerns the gene CD38 and neoplasm.